AIM-quoted One Health Group (LSE:OHGR) said first-half revenue rose 17% to £18.3 million and that underlying EBITDA is expected to come in ahead of the prior year. The board said the group remains on track to meet market expectations for the full year.
What was announced
One Health Group plc (LSE:OHGR), which provides NHS-funded elective surgery through the independent sector, published a trading update on 26 October 2026. It covers the six months to 30 September 2026, which the company calls H1 27. The company said the announcement contains inside information.
The update said H1 27 revenue and EBITDA were "significantly ahead of prior year". Revenue for the half was £18.3 million, up 17% from £15.6 million a year earlier. The company did not give an exact EBITDA figure. It said underlying EBITDA for the half is expected to be ahead of the £1.18 million reported for H1 FY26, helped by higher activity and operational progress.
The numbers
Activity grew faster than revenue. New NHS patient referrals rose 24% to 11,275, from 9,111. Consultations also rose 24%, to 29,755 from 23,927. Surgical procedures increased 13% to 4,517, from 4,009.
The company has added capacity. It now runs 46 outreach clinics, up from 40, and 14 surgical operating facilities, up from 12. The consultant base, excluding anaesthetists, stood at 82, compared with 80 a year earlier.
That consultant figure follows a deliberate reduction. One Health said it cut its consultant pool from 88 in March 2026 to improve productivity, and that a further 12 consultants are under review to support future growth. Annualised revenue per consultant rose 17% to 446k, from 391k (the company gives the figure in thousands).
Background
One Health links its growth to sustained pressure on NHS waiting lists. The update put the national waiting list at about 7.1 million in March 2026, about 7.3 million in May 2026 and about 7.4 million in August 2026. The company expects continued demand for independent-sector capacity to treat NHS patients.
It also flagged a risk from the planned abolition of NHS England. That reorganisation is expected to be completed by March 2027, subject to Parliamentary approval, and the company noted that it could cause disruption. The announcement did not say how this might affect referral flows for One Health.
The group is building its first dedicated surgical hub. It said the building's shell is now weather-tight and that it expects the hub to open in Spring 2027. It has also identified a possible site for a second hub.
Chief executive Adam Binns praised the team's performance and said: "Activity was ahead of both the corresponding period last year and the second half of FY26." He said he expects further activity from NHS Trusts in the second half, but noted that this work is not contracted or guaranteed.
What to watch next
The board said the group remains on track for its expected FY27 revenue growth and underlying EBITDA, in line with market consensus of £33.2 million to £34.0 million for revenue and £2.6 million for underlying EBITDA. These consensus figures are analyst forecasts, not company guidance.
On the disclosed figures, H1 27 revenue of £18.3 million is about 55% of the bottom of the consensus revenue range. Meeting consensus would need second-half revenue of roughly £14.9 million to £15.7 million. For EBITDA, a first half above £1.18 million means less than £1.42 million would be needed from the second half to reach £2.6 million.
Half-year results are due in late November 2026 and should give exact EBITDA figures and more detail on margins and cash. Investors will also be watching for news on the surgical hub's timing, the outcome of the consultant review, and how the NHS England transition affects demand.
_11_16_2026_14_47_34_233787.jpg)





Please wait processing your request...